Common and Rare EGFR and KRAS Mutations in a Dutch Non-Small-Cell Lung Cancer Population and Their Clinical Outcome-Reference-Cited by-同舟云学术

Common and Rare EGFR and KRAS Mutations in a Dutch Non-Small-Cell Lung Cancer Population and Their Clinical Outcome

Published:2013-07-29 Issue:7 Volume:8 Page:e70346
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kerner Gerald S. M. A.,Schuuring Ed,Sietsma Johanna,Hiltermann Thijo J. N.,Pieterman Remge M.,de Leede Gerard P. J.,van Putten John W. G.,Liesker Jeroen,Renkema Tineke E. J.,van Hengel Peter,Platteel Inge,Timens Wim,Groen Harry J. M.,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer;R Maruyama;J Clin Oncol,2008

2. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;TS Mok;N Engl J Med,2009

3. Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial;JY Douillard;J Clin Oncol,2010

4. Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study;T Ciuleanu;Lancet Oncol,2012

5. Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial;ES Kim;Lancet,2008

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Presence of EGFR T790M in TKI-Naïve Lung Cancer Samples of Patients Who Developed a T790M-Positive Relapse on First or Second Generation TKI Is Rare;Cancers;2022-07-19

2. Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis;Targeted Oncology;2022-02-28

3. Reporting of Incidence and Outcome of Bone Metastases in Clinical Trials Enrolling Patients with Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma—A Systematic Review;Cancers;2021-06-23

4. Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing;Expert Review of Pharmacoeconomics & Outcomes Research;2021-05-04

5. Spectrum of uncommon and compound epidermal growth factor receptor mutations in non-small-cell lung carcinomas with treatment response and outcome analysis: A study from India;Lung Cancer;2020-11